AAAAAA

   
Results: 1-12 |
Results: 12

Authors: HUMPHREY RW DAVIS DA NEWCOMB FM YARCHOAN R
Citation: Rw. Humphrey et al., HUMAN-HERPESVIRUS-8 (HHV-8) IN THE PATHOGENESIS OF KAPOSIS-SARCOMA AND OTHER DISEASES, Leukemia & lymphoma, 28(3-4), 1998, pp. 255-264

Authors: WELLES L SAVILLE MW LIETZAU J PLUDA JM WYVILL KM FEUERSTEIN I FIGG WD LUSH R ODOM J WILSON WH FAJARDO MT HUMPHREY RW FEIGAL E TUCK D STEINBERG SM BRODER S YARCHOAN R
Citation: L. Welles et al., PHASE-II TRIAL WITH DOSE TITRATION OF PACLITAXEL FOR THE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA, Journal of clinical oncology, 16(3), 1998, pp. 1112-1121

Authors: PERNO CF NEWCOMB FM DAVIS DA AQUARO S HUMPHREY RW CALIO R YARCHOAN R
Citation: Cf. Perno et al., RELATIVE POTENCY OF PROTEASE INHIBITORS IN MONOCYTES MACROPHAGES ACUTELY AND CHRONICALLY INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, The Journal of infectious diseases, 178(2), 1998, pp. 413-422

Authors: HUMPHREY RW DAVIS DA NEWCOMB FM OBRIEN TR GOEDERT JJ STRAUS SE PASS R YARCHOAN R
Citation: Rw. Humphrey et al., ANALYSIS OF HUMAN HERPESVIRUS-8 INFECTION IN CHILDREN AND ADULTS BY MEASURING SERUM ANTIBODIES TO A PEPTIDE OF A MINOR CAPSID PROTEIN OR BYPCR, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 74-74

Authors: HUMPHREY RW OHAGEN A DAVIS DA FUKAZAWA T HAYASHI H HOGLUND S MITSUYA H YARCHOAN R
Citation: Rw. Humphrey et al., REMOVAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE INHIBITORS FROM PREPARATIONS OF IMMATURE HIV-1 VIRIONS DOES NOT RESULT IN AN INCREASE IN INFECTIVITY OR THE APPEARANCE OF MATURE MORPHOLOGY, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 1017-1023

Authors: DAVIS DA HUMPHREY RW NEWCOMB FM OBRIEN TR GOEDERT JJ STRAUS SE YARCHOAN R
Citation: Da. Davis et al., DETECTION OF SERUM ANTIBODIES TO A KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-SPECIFIC PEPTIDE, The Journal of infectious diseases, 175(5), 1997, pp. 1071-1079

Authors: HUMPHREY RW DAVIS DA MITSUYA H YARCHOAN R
Citation: Rw. Humphrey et al., HIV VIRIONS PRODUCED BY CELLS TREATED WITH THE HIV-1 PROTEASE INHIBITOR KNI-272 DO NOT ACQUIRE INFECTIVITY AFTER VIRAL BUDDING, Journal of investigative medicine, 44(3), 1996, pp. 252-252

Authors: HUMPHREY RW OBRIEN TR NEWCOMB FM NISHIHARA H WYVILL KM RAMOS GA SAVILLE MW GOEDERT JJ STRAUS SE YARCHOAN R
Citation: Rw. Humphrey et al., KAPOSIS-SARCOMA (KS)-ASSOCIATED HERPESVIRUS-LIKE DNA-SEQUENCES IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - ASSOCIATION WITH KS AND PERSISTENCE IN PATIENTS RECEIVING ANTI-HERPESVIRUS DRUGS, Blood, 88(1), 1996, pp. 297-301

Authors: HUMPHREY RW NISHIHARA H SAVILLE MW STRAUS SE YARCHOAN R
Citation: Rw. Humphrey et al., DETECTION OF KAPOSIS-SARCOMA-ASSOCIATED HERPES-VIRUS (KSHV) DNA-SEQUENCES IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC) OBTAINED FROM HIV KAPOSIS-SARCOMA (KS) PATIENTS WITHOUT AND DURING THERAPY, AIDS research and human retroviruses, 11, 1995, pp. 98-98

Authors: HUMPHREY RW SAVILLE MW MITSUYA H YARCHOAN R
Citation: Rw. Humphrey et al., HIV-1 PROTEASE FUNCTION PRIOR TO VIRAL BUDDING IS ESSENTIAL FOR THE PRODUCTION OF INFECTIOUS VIRIONS, AIDS research and human retroviruses, 11, 1995, pp. 162-162

Authors: SAVILLE MW LIETZAU J PLUDA JM FEUERSTEIN I ODOM J WILSON WH HUMPHREY RW FEIGAL E STEINBERG SM BRODER S YARCHOAN R
Citation: Mw. Saville et al., TREATMENT OF HIV-ASSOCIATED KAPOSIS-SARCOMA WITH PACLITAXEL, Lancet, 346(8966), 1995, pp. 26-28

Authors: DAVIS DA BRANCA AA PALLENBERG AJ MARSCHNER TM PATT LM CHATLYNNE LG HUMPHREY RW YARCHOAN R LEVINE RL
Citation: Da. Davis et al., INHIBITION OF THE HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE AND HUMAN IMMUNODEFICIENCY VIRUS-1 REPLICATION BY BATHOCUPROINE DISULFONIC ACID CU1+, Archives of biochemistry and biophysics, 322(1), 1995, pp. 127-134
Risultati: 1-12 |